台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    69.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    112
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-陽信-石牌 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

陽信-石牌 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/0100.00154.1054.80-1183-0.54%
2023/11/1400.001.134.5534.90-1.1158-0.69%
2023/11/1300.00134.5034.20-1154-0.65%
2022/07/2700.00114.2514.15-1109-0.92%
2022/07/26115.0500.0015.0511020.97%
2022/05/0500.001015.0515.00-10140-7.12%
2022/04/2100.00115.0515.00-1116-0.86%
2022/04/1900.00315.5715.35-3105-2.84%
2022/04/181316.2200.0016.95139214.10%
2021/12/2000.00216.8016.60-2114-1.75%
2021/12/03216.2000.0016.2021051.90%
2021/08/2300.001015.6015.65-10143-6.96%
2021/08/2000.00415.5515.55-4152-2.63%
2021/05/1900.00517.3016.95-5547-0.91%
2021/05/18518.0000.0017.9055350.93%
2021/05/1400.00120.0017.90-1459-0.22%
2021/05/13618.7800.0019.5564341.38%
2021/04/1200.00217.7018.80-2294-0.68%
2021/04/08217.2500.0017.2522730.73%
2021/03/2900.00316.5816.50-3271-1.11%
2021/03/26216.4000.0016.3522770.72%
2021/03/2500.00617.0016.55-6278-2.15%
2021/03/24616.78116.8516.8052741.82%
2021/03/18116.6000.0016.5512670.37%
2021/03/0800.00217.2317.25-2271-0.74%
2021/03/05217.6800.0017.8522650.75%
2021/02/0100.00415.5015.25-4197-2.02%
2020/12/1100.00317.2217.15-3351-0.85%
2020/11/09318.3700.0018.4034220.71%
2020/10/2900.00118.7019.45-1497-0.20%
2020/10/20119.8000.0019.8015460.18%
2020/09/11118.4000.0018.1011,4170.07%
2020/09/04119.5000.0019.4011,8090.06%
2020/08/2600.00221.0320.95-21,940-0.10%
2020/08/2400.00220.9020.80-21,982-0.10%
2020/08/20220.101019.9319.70-82,121-0.38%
2020/08/1900.00121.8521.80-12,128-0.05%
2020/08/1200.00123.7023.80-12,327-0.04%
2020/08/10223.63123.9023.7012,3120.04%
2020/08/06224.2500.0024.3022,3020.09%
2020/08/0500.00124.9525.05-12,289-0.04%
2020/08/04225.6000.0025.5022,2780.09%
2020/07/31224.5000.0024.6522,2630.09%
2020/07/30125.0000.0025.2512,2720.04%
2020/07/291025.0000.0025.55102,2730.44%
2020/07/27325.0700.0024.9032,2480.13%
2020/07/2300.00130.4028.80-12,233-0.04%
2020/07/22129.8000.0030.0012,2040.05%
2020/07/2100.001127.0327.45-112,149-0.51%
2020/07/20124.9500.0025.0012,1090.05%
2020/07/17726.4400.0026.1572,0680.34%
2020/07/16429.7900.0029.0542,0180.20%
2020/07/15130.00129.0030.8001,9830.00%
2020/07/1400.00230.5029.60-21,907-0.10%
2020/07/13329.75431.1531.55-11,793-0.06%
2020/07/10228.70228.7028.7001,6660.00%
2020/07/07321.1200.0021.6031,5050.20%
2020/07/06223.4000.0023.1521,4760.14%
2020/06/3000.00123.2023.45-11,416-0.07%
2020/06/17225.80125.2025.3511,3500.07%
2020/06/16525.21124.5025.9041,2940.31%
2020/06/15223.18223.5024.2001,2070.00%
2020/06/12220.6000.0022.0021,1240.18%
2020/06/1100.00221.0021.00-21,077-0.19%
2020/06/1000.003819.0819.10-38985-3.85%
2020/06/09616.974117.7717.40-35958-3.65%
2020/06/042917.23317.2017.00269552.72%
2020/06/031217.3600.0017.60129631.25%
2020/06/021017.66116.7016.6099660.93%
2020/05/29918.6500.0018.5099730.92%
2020/05/28518.30318.0518.5029780.20%
2020/05/271119.45119.4519.45109471.06%
2020/05/26121.6000.0021.6019020.11%
2020/05/22717.29117.5017.9069300.65%
2020/05/20114.8500.0014.8518270.12%
2020/05/0700.00112.7512.55-1767-0.13%
2020/05/04111.7000.0012.4017240.14%
2020/03/1700.0049.019.00-4632-0.63%
2020/03/0200.00214.6014.60-2397-0.50%
2020/01/060.310.5000.0010.600.3980.31%
2019/08/0800.002.210.8010.75-2.2148-1.46%
2019/04/250.412.0000.0012.100.41130.33%
2019/04/18512.4500.0012.3051483.36%
2019/03/15213.2500.0012.9021451.38%
2019/03/05012.0500.0012.0501270.00%
2018/11/140.413.2000.0013.100.4860.42%
2018/11/130.113.2000.0013.200.1860.12%
2018/09/120.116.9000.0016.850.11210.07%
2018/05/0300.00219.3519.35-2382-0.52%
2018/04/16221.8000.0021.3523290.61%
2018/04/1200.00322.4522.00-3249-1.20%
2018/02/2600.00420.0019.50-4207-1.92%
2018/01/17419.0000.0019.0541922.08%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音